EvilThe startup offering a 90-second test kiosk, which provides prescriptions of glasses verified by doctors, secured $ 20 million in financing of the A series.
The startup from Boston, founded in 2021, entitles the way people gain access to view, eliminating traditional obstacles, equivalent to delays in meetings, limited availability, complex insurance requirements and costs.
His kiosks, already found in shopping centers, universities, retail stores, pharmacies, food chains, schools and airports, provide a free 90-second vision test. According to the company, each test generates a prescription, which is then checked and approved by licensed eye doctors, providing quick, comfortable and reliable prescriptions.
New funds, which are conducting total Eyebot funds to over $ 30 million, appears about a 12 months after the startup raised its round grain in June 2024. Since then, the startup conducted over 45,000 free vision tests and is on the right track to deliver over half a million a 12 months, he says.
“From our round of seeds the change was dramatic. We went from piloting to cooperation with some of the largest companies in the USA, launching kiosks throughout the country and providing tens of thousands of vision tests,” said TechCrunch Matthias Hofmann, co-founder and general director of Eyebot. “The revenues are scaling, and our team has doubled. Most importantly, we have proved that the model works: people use the pull -up knob, doctors are bound by the results, and retailers are excited about the movement he leads.”
Hofmann said that what distinguishes Eybot is a combination of convenience and medical assurance. Each test is checked by a doctor, and all prescriptions are issued as a part of clinical supervision. If the test results indicate something extraordinary, patients are referred to personal, comprehensive tests. He says that the balance of speed plus clinical supervision provides trust.
“In our locations in the shopping center we saw surprising downloading of parents with children,” said Hofmann. “They will stop between shops, try the Eybobot – sometimes even when holding children’s hands – and come out with a prescription in just a few minutes.”
TechCrunch event
San Francisco
|.
October 27-29 2025
Convincing traditional healthcare providers that the technological approach has proved to be difficult. Early skepticism was deeply: doctors are apprehensive about accuracy, while patients asked if the process could possibly be reliable, according to Hofmann. He says that hesitation has softened when the suppliers learned that the experience of doctors check every result, many with over a decade of experience.
Eybot is in the early stages of commercialization. His vision test is offered freed from charge to consumers, and if a prescription is needed, one of the company’s doctors verifies it for a fee. In addition, the company rents kiosks to optical details, glasses and independent practices.
The general director said that thanks to the A series, the company plans to scale the implementation of a kiosk and expand its team to products, clinical operations and industrial growth.
General Catalyst led the last round and included the participation of recurring Investors Alleycorp, Baukunst, Village Global, Humba Venture, Ravelin and Ubiquity Ventures.